Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-09

AUTHORS

Jae Min Jeong, Jaetae Lee, Chang Hum Paik, Dae-Kee Kim, Dong Soo Lee, June-Key Chung, Myung Chul Lee

ABSTRACT

The development of an antibody labeling method with99mTc is important for cancer imaging. Most bifunctional chelate methods for99mTc labeling of antibody incorporate a99mTc chelator through a linkage to lysine residue. In the present study, a novel site-specific99mTc labeling method at carbohydrate side chain in the Fc region of 2 antibodies (T101 and rabbit antihuman serum albumin antibody (RPAb)) using dihydrazinophthalazine (DHZ) which has 2 hydrazino groups was developed. The antibodies were oxidized with sodium periodate to produce aldehyde on the Fc region. Then, one hydrazine group of DHZ was conjugated with an aldehyde group of antibody through the formation of a hydrazone. The other hydrazine group was used for labeling with99mTc. The number of conjugated DHZ was 1.7 per antibody.99mTc labeling efficiency was 46~85% for T101 and 67~87% for RPAb. Indirect labeling with DHZ conjugated antibodies showed higher stability than direct labeling with reduced antibodies. High immunoreactivities were conserved for both indirectly and directly labeled antibodies. A biodistribution study found high blood activity related to directly labeled T101 at early time point as well as low liver activity due to indirectly labeled T101 at later time point. However, these findings do not affect practical use. No significantly different biodistribution was observed in the other organs. The research concluded that DHZ can be used as a site-specific bifunctional chelating agent for labeling antibody with99mTc. Moreover,99mTc labeled antibody via DHZ was found to have excellent chemical and biological properties for nuclear medicine imaging. More... »

PAGES

961-967

Journal

TITLE

Archives of Pharmacal Research

ISSUE

9

VOLUME

27

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02975851

DOI

http://dx.doi.org/10.1007/bf02975851

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038220626

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15473668


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Binding Sites, Antibody", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dihydralazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Fc Fragments", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Heavy Chains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isotope Labeling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Technetium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, USA", 
            "Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Kyungpook National University School of Medicine, 700-721, Daegu, Korea", 
          "id": "http://www.grid.ac/institutes/grid.258803.4", 
          "name": [
            "Department of Nuclear Medicine, Kyungpook National University School of Medicine, 700-721, Daegu, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Jaetae", 
        "id": "sg:person.01324611777.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324611777.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, MD20892, Bethesda, USA", 
          "id": "http://www.grid.ac/institutes/grid.410305.3", 
          "name": [
            "Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, MD20892, Bethesda, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paik", 
        "givenName": "Chang Hum", 
        "id": "sg:person.0631265256.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631265256.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Ewha Womans University, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.255649.9", 
          "name": [
            "Department of Pharmacy, Ewha Womans University, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Dae-Kee", 
        "id": "sg:person.01076502162.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076502162.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, USA", 
            "Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung Chul", 
        "id": "sg:person.01337220140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2004-09", 
    "datePublishedReg": "2004-09-01", 
    "description": "The development of an antibody labeling method with99mTc is important for cancer imaging. Most bifunctional chelate methods for99mTc labeling of antibody incorporate a99mTc chelator through a linkage to lysine residue. In the present study, a novel site-specific99mTc labeling method at carbohydrate side chain in the Fc region of 2 antibodies (T101 and rabbit antihuman serum albumin antibody (RPAb)) using dihydrazinophthalazine (DHZ) which has 2 hydrazino groups was developed. The antibodies were oxidized with sodium periodate to produce aldehyde on the Fc region. Then, one hydrazine group of DHZ was conjugated with an aldehyde group of antibody through the formation of a hydrazone. The other hydrazine group was used for labeling with99mTc. The number of conjugated DHZ was 1.7 per antibody.99mTc labeling efficiency was 46~85% for T101 and 67~87% for RPAb. Indirect labeling with DHZ conjugated antibodies showed higher stability than direct labeling with reduced antibodies. High immunoreactivities were conserved for both indirectly and directly labeled antibodies. A biodistribution study found high blood activity related to directly labeled T101 at early time point as well as low liver activity due to indirectly labeled T101 at later time point. However, these findings do not affect practical use. No significantly different biodistribution was observed in the other organs. The research concluded that DHZ can be used as a site-specific bifunctional chelating agent for labeling antibody with99mTc. Moreover,99mTc labeled antibody via DHZ was found to have excellent chemical and biological properties for nuclear medicine imaging.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02975851", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4054747", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2713456", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1090680", 
        "issn": [
          "0253-6269", 
          "1976-3786"
        ], 
        "name": "Archives of Pharmacal Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "time points", 
      "Fc region", 
      "lower liver activity", 
      "later time points", 
      "higher blood activity", 
      "early time points", 
      "high immunoreactivity", 
      "blood activity", 
      "liver activity", 
      "nuclear medicine imaging", 
      "biodistribution studies", 
      "antibodies", 
      "reduced antibody", 
      "T101", 
      "medicine imaging", 
      "with99mTc", 
      "present study", 
      "conjugated antibodies", 
      "cancer imaging", 
      "heavy chain", 
      "bifunctional chelating agent", 
      "group", 
      "different biodistribution", 
      "indirect labeling", 
      "imaging", 
      "carbohydrate side chains", 
      "immunoreactivity", 
      "labeling efficiency", 
      "labeling", 
      "biodistribution", 
      "activity", 
      "organs", 
      "study", 
      "direct labeling", 
      "labeling method", 
      "biological properties", 
      "agents", 
      "labeling of antibodies", 
      "chelators", 
      "findings", 
      "dihydrazinophthalazine", 
      "sodium periodate", 
      "hydrazine group", 
      "chelating agent", 
      "use", 
      "region", 
      "hydrazino group", 
      "development", 
      "number", 
      "conjugation", 
      "RpaB", 
      "point", 
      "periodate", 
      "research", 
      "method", 
      "linkage", 
      "chemicals", 
      "formation", 
      "excellent chemical", 
      "high stability", 
      "side chains", 
      "residues", 
      "chain", 
      "hydrazones", 
      "aldehyde groups", 
      "practical use", 
      "properties", 
      "aldehydes", 
      "efficiency", 
      "stability"
    ], 
    "name": "Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain", 
    "pagination": "961-967", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038220626"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02975851"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15473668"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02975851", 
      "https://app.dimensions.ai/details/publication/pub.1038220626"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_391.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02975851"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02975851'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02975851'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02975851'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02975851'


 

This table displays all metadata directly associated to this object as RDF triples.

237 TRIPLES      20 PREDICATES      108 URIs      100 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02975851 schema:about N0f5fd293ab6241cb9a660c5e4d8ed30d
2 N4927b78796574760ba604cb694a6279d
3 N53c4768029b9401a852f9f5ac0755c2f
4 N5eb051bead9141098e964d47b8fba81e
5 N7a2f5c773d984af39543ffeb18d4800c
6 N83d8466f410b4882a32c5051a280788c
7 N86aefd7a05584ed8b62828a46fecde68
8 N8aa40e3628fe4314b4ecf27580d8a19e
9 N8e36936a4d864606b74fc6ca1d19187d
10 N972c5ffd9a134c56a784c3180c40f029
11 N998485eb362b4b6fa3a1c2443748cdcd
12 Nfc1c3d6eb4eb427cbf378828e55deaa9
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N27604a92137a43a69681f7bed2210ac6
16 schema:datePublished 2004-09
17 schema:datePublishedReg 2004-09-01
18 schema:description The development of an antibody labeling method with99mTc is important for cancer imaging. Most bifunctional chelate methods for99mTc labeling of antibody incorporate a99mTc chelator through a linkage to lysine residue. In the present study, a novel site-specific99mTc labeling method at carbohydrate side chain in the Fc region of 2 antibodies (T101 and rabbit antihuman serum albumin antibody (RPAb)) using dihydrazinophthalazine (DHZ) which has 2 hydrazino groups was developed. The antibodies were oxidized with sodium periodate to produce aldehyde on the Fc region. Then, one hydrazine group of DHZ was conjugated with an aldehyde group of antibody through the formation of a hydrazone. The other hydrazine group was used for labeling with99mTc. The number of conjugated DHZ was 1.7 per antibody.99mTc labeling efficiency was 46~85% for T101 and 67~87% for RPAb. Indirect labeling with DHZ conjugated antibodies showed higher stability than direct labeling with reduced antibodies. High immunoreactivities were conserved for both indirectly and directly labeled antibodies. A biodistribution study found high blood activity related to directly labeled T101 at early time point as well as low liver activity due to indirectly labeled T101 at later time point. However, these findings do not affect practical use. No significantly different biodistribution was observed in the other organs. The research concluded that DHZ can be used as a site-specific bifunctional chelating agent for labeling antibody with99mTc. Moreover,99mTc labeled antibody via DHZ was found to have excellent chemical and biological properties for nuclear medicine imaging.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N3c2a2497935241c1b0ded814c2afed0d
22 N470e978a892f454280143928bf4391e0
23 sg:journal.1090680
24 schema:keywords Fc region
25 RpaB
26 T101
27 activity
28 agents
29 aldehyde groups
30 aldehydes
31 antibodies
32 bifunctional chelating agent
33 biodistribution
34 biodistribution studies
35 biological properties
36 blood activity
37 cancer imaging
38 carbohydrate side chains
39 chain
40 chelating agent
41 chelators
42 chemicals
43 conjugated antibodies
44 conjugation
45 development
46 different biodistribution
47 dihydrazinophthalazine
48 direct labeling
49 early time points
50 efficiency
51 excellent chemical
52 findings
53 formation
54 group
55 heavy chain
56 high immunoreactivity
57 high stability
58 higher blood activity
59 hydrazine group
60 hydrazino group
61 hydrazones
62 imaging
63 immunoreactivity
64 indirect labeling
65 labeling
66 labeling efficiency
67 labeling method
68 labeling of antibodies
69 later time points
70 linkage
71 liver activity
72 lower liver activity
73 medicine imaging
74 method
75 nuclear medicine imaging
76 number
77 organs
78 periodate
79 point
80 practical use
81 present study
82 properties
83 reduced antibody
84 region
85 research
86 residues
87 side chains
88 sodium periodate
89 stability
90 study
91 time points
92 use
93 with99mTc
94 schema:name Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain
95 schema:pagination 961-967
96 schema:productId N06653f8874bc46c79c1116aa711e6fb1
97 N62c6f61070224789bd75c37fa1a1c013
98 N9f3074496faa47a2a1df2a1f87778406
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038220626
100 https://doi.org/10.1007/bf02975851
101 schema:sdDatePublished 2022-10-01T06:32
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher N4428425d5d5e47269b576341c638d504
104 schema:url https://doi.org/10.1007/bf02975851
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N06653f8874bc46c79c1116aa711e6fb1 schema:name dimensions_id
109 schema:value pub.1038220626
110 rdf:type schema:PropertyValue
111 N0f5fd293ab6241cb9a660c5e4d8ed30d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Immunoglobulin Fc Fragments
113 rdf:type schema:DefinedTerm
114 N1acf4449442f4eaca9b4530d2e512f0d rdf:first sg:person.01324611777.37
115 rdf:rest N21694f5137ba4f418eaa155382cbaa3e
116 N21694f5137ba4f418eaa155382cbaa3e rdf:first sg:person.0631265256.31
117 rdf:rest Nfe65dc66b33c4c24bc0060f7659de9ca
118 N27604a92137a43a69681f7bed2210ac6 rdf:first sg:person.01301360400.94
119 rdf:rest N1acf4449442f4eaca9b4530d2e512f0d
120 N3c2a2497935241c1b0ded814c2afed0d schema:issueNumber 9
121 rdf:type schema:PublicationIssue
122 N4428425d5d5e47269b576341c638d504 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 N470e978a892f454280143928bf4391e0 schema:volumeNumber 27
125 rdf:type schema:PublicationVolume
126 N4927b78796574760ba604cb694a6279d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Binding Sites, Antibody
128 rdf:type schema:DefinedTerm
129 N4f6b4c368168429c8207540719882e83 schema:affiliation grid-institutes:None
130 schema:familyName Lee
131 schema:givenName Dong Soo
132 rdf:type schema:Person
133 N53c4768029b9401a852f9f5ac0755c2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N56867d529eb74821a801e168c367b1c0 rdf:first sg:person.01337220140.25
137 rdf:rest rdf:nil
138 N5eb051bead9141098e964d47b8fba81e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Mice
140 rdf:type schema:DefinedTerm
141 N62c6f61070224789bd75c37fa1a1c013 schema:name doi
142 schema:value 10.1007/bf02975851
143 rdf:type schema:PropertyValue
144 N7a2f5c773d984af39543ffeb18d4800c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Mice, Inbred BALB C
146 rdf:type schema:DefinedTerm
147 N83d8466f410b4882a32c5051a280788c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Animals
149 rdf:type schema:DefinedTerm
150 N86aefd7a05584ed8b62828a46fecde68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Immunoglobulin Heavy Chains
152 rdf:type schema:DefinedTerm
153 N8aa40e3628fe4314b4ecf27580d8a19e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 N8e36936a4d864606b74fc6ca1d19187d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Tissue Distribution
158 rdf:type schema:DefinedTerm
159 N972c5ffd9a134c56a784c3180c40f029 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Technetium
161 rdf:type schema:DefinedTerm
162 N998485eb362b4b6fa3a1c2443748cdcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Isotope Labeling
164 rdf:type schema:DefinedTerm
165 N9f3074496faa47a2a1df2a1f87778406 schema:name pubmed_id
166 schema:value 15473668
167 rdf:type schema:PropertyValue
168 Nd7786163152d48a6aea1a40b54b12dda rdf:first sg:person.0751347234.39
169 rdf:rest N56867d529eb74821a801e168c367b1c0
170 Nedc40406351d42eaae45bfb72ffe8ce5 rdf:first N4f6b4c368168429c8207540719882e83
171 rdf:rest Nd7786163152d48a6aea1a40b54b12dda
172 Nfc1c3d6eb4eb427cbf378828e55deaa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Dihydralazine
174 rdf:type schema:DefinedTerm
175 Nfe65dc66b33c4c24bc0060f7659de9ca rdf:first sg:person.01076502162.44
176 rdf:rest Nedc40406351d42eaae45bfb72ffe8ce5
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
181 schema:name Clinical Sciences
182 rdf:type schema:DefinedTerm
183 sg:grant.2713456 http://pending.schema.org/fundedItem sg:pub.10.1007/bf02975851
184 rdf:type schema:MonetaryGrant
185 sg:grant.4054747 http://pending.schema.org/fundedItem sg:pub.10.1007/bf02975851
186 rdf:type schema:MonetaryGrant
187 sg:journal.1090680 schema:issn 0253-6269
188 1976-3786
189 schema:name Archives of Pharmacal Research
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01076502162.44 schema:affiliation grid-institutes:grid.255649.9
193 schema:familyName Kim
194 schema:givenName Dae-Kee
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076502162.44
196 rdf:type schema:Person
197 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
198 schema:familyName Jeong
199 schema:givenName Jae Min
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
201 rdf:type schema:Person
202 sg:person.01324611777.37 schema:affiliation grid-institutes:grid.258803.4
203 schema:familyName Lee
204 schema:givenName Jaetae
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324611777.37
206 rdf:type schema:Person
207 sg:person.01337220140.25 schema:affiliation grid-institutes:None
208 schema:familyName Lee
209 schema:givenName Myung Chul
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25
211 rdf:type schema:Person
212 sg:person.0631265256.31 schema:affiliation grid-institutes:grid.410305.3
213 schema:familyName Paik
214 schema:givenName Chang Hum
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631265256.31
216 rdf:type schema:Person
217 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
218 schema:familyName Chung
219 schema:givenName June-Key
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
221 rdf:type schema:Person
222 grid-institutes:None schema:alternateName Department of Nuclear Medicine, USA
223 schema:name Department of Nuclear Medicine, USA
224 rdf:type schema:Organization
225 grid-institutes:grid.255649.9 schema:alternateName Department of Pharmacy, Ewha Womans University, Seoul, Korea
226 schema:name Department of Pharmacy, Ewha Womans University, Seoul, Korea
227 rdf:type schema:Organization
228 grid-institutes:grid.258803.4 schema:alternateName Department of Nuclear Medicine, Kyungpook National University School of Medicine, 700-721, Daegu, Korea
229 schema:name Department of Nuclear Medicine, Kyungpook National University School of Medicine, 700-721, Daegu, Korea
230 rdf:type schema:Organization
231 grid-institutes:grid.31501.36 schema:alternateName Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea
232 schema:name Cancer Research Institute, Seoul National University College of Medicine, 110-744, Seoul, Korea
233 Department of Nuclear Medicine, USA
234 rdf:type schema:Organization
235 grid-institutes:grid.410305.3 schema:alternateName Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, MD20892, Bethesda, USA
236 schema:name Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, MD20892, Bethesda, USA
237 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...